🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase 2b study will evaluate the efficacy and safety of 16 and 24 week...
Status
Completed
Location
Digestive Health Specialists of the Southeast
Start Date
2010-10
Trial ID
NCT01271790
By chance the investigators found that iv. silibinin has a potent antiviral...
Status
Completed
Location
Medical University of Vienna
Start Date
2007-10
Trial ID
NCT00684268
The primary objective of this study is to estimate, in HCV genotype 1 or 4-...
Status
Completed
Location
ASSELAH Tarik
Start Date
2016-01
Trial ID
NCT02647632
Treatments Being Tested
This study will examine the viral kinetics and pharmacokinetics of Pegasys ...
Status
Completed
Location
Multiple Locations
Start Date
2004-01
Trial ID
NCT00087607
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of co-admi...
Status
Completed
Location
Multiple Locations
Start Date
2012-08
Trial ID
NCT01685203
Treatments Being Tested
This randomized, double-blind, multi-center, placebo-controlled, parallel-g...
Status
Completed
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01482403
The purpose of this study is to investigate the effectiveness and safety of...
Status
Completed
Location
Multiple Locations
Start Date
2011-02
Trial ID
NCT01281839
Treatments Being Tested
This single arm study will investigate the predictive value of a week 4 vir...
Status
Completed
Location
Multiple Locations
Start Date
2008-11
Trial ID
NCT00700401
Treatments Being Tested
The aims of this three-year study are to explore symptom experience and its...
Status
Unknown
Location
National Taiwan University Hospital
Start Date
2007-09
Trial ID
NCT01178749
To assess the pharmacokenetic characteristics of 600 mg BID BI 207127 / 120...
Status
Completed
Location
1241.30.10003 Boehringer Ingelheim Investigational Site
Start Date
2013-04
Trial ID
NCT01830127
Treatments Being Tested